BPG is committed to discovery and dissemination of knowledge
Basic Study
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Aug 15, 2026; 18(8): 119026
Published online Aug 15, 2026. doi: 10.4251/wjgo.119026
Table 1 Comparison of general characteristics among patients with different diseases, mean ± SD/n (%)
Group
n
Gender (male/female)
Age (years)
BMI (kg/m2)
Helicobacter pylori positivity
Erosive gastritis group4523 (51.11)/22 (48.89) 50.66 ± 5.3122.87 ± 3.0213 (28.89)
Gastrointestinal polyp group147 (50.00)/7 (50.00) 55.49 ± 5.7823.04 ± 2.954 (28.57)
Peptic ulcer group2410 (41.67)/14 (58.33) 52.41 ± 5.0223.22 ± 3.086 (25.00)
Gastrointestinal tumor group104 (40.00)/6 (60.00) 66.20 ± 6.97a22.41 ± 2.903 (30.00)
F/χ2-0.8319.320.1760.154
P value-0.843< 0.0010.9130.991
Table 2 Comparison of Streptococcus pharyngitidis positivity rate and relative bacterial load among patients with different gastrointestinal diseases, n (%)
Group
n
Mucosal positivity
Luminal content positivity
Erosive gastritis group456 (13.33) 5 (11.11)
Gastrointestinal polyp group144 (28.57) 3 (21.43)
Peptic ulcer group247 (29.17) 5 (20.83)
Gastrointestinal tumor group108 (80.00)a6 (60.00)a
χ2/H-10.2138.014
P value-0.0170.046
Table 3 Comparison of Streptococcus pharyngitidis positivity rates and bacterial load in different anatomical sites among patients with various gastrointestinal diseases, n (%)/median (interquartile range)
Group
n
Lesional mucosa positivity
Distal mucosa positivity
Gastric juice/feces positivity
Relative bacterial load (lesional mucosa, 2-ΔΔCt)
Relative bacterial load (distal mucosa, 2-ΔΔCt)
Relative bacterial load (gastric juice/feces, 2-ΔΔCt)
Erosive gastritis group456 (13.33) 3 (6.67) 4 (8.87) 0.18 (0.10, 0.32) 0.12 (0.06, 0.25) 0.16 (0.09, 0.28)
Gastrointestinal polyp group144 (28.57) 1 (7.14) 2 (14.29) 0.34 (0.20, 0.55) 0.21 (0.12, 0.39) 0.30 (0.18, 0.48)
Peptic ulcer group247 (29.17) 5 (20.83) 6 (25.00) 0.36 (0.22, 0.60) 0.24 (0.18, 0.41) 0.32 (0.20, 0.50)
Gastrointestinal tumor group108 (80.00)a6 (60.00) 5 (50.00) 0.92 (0.65, 1.35)a,b0.61 (0.42, 1.06)a0.82 (0.55, 1.20)a
χ2/H-10.2137.868.4044.038.642.7
P value-0.0170.0440.038< 0.001< 0.001< 0.001
Table 4 Comparison of Streptococcus pharyngitidis positivity rates among patients with different clinical-pathological characteristics, n (%)
Clinicopathological characteristics
n = 10
S. anginosus
P value
Positive
Negative
Degree of mucosal inflammation< 0.0011
Mild-moderate63 (50.00) 3 (50.00)
Severe44 (100.00) 0 (0.00)
TNM staging< 0.0011
Stage I-II62 (50.00) 4 (50.00)
Stage III-IV44 (100.00) 0 (0.00)
Lymph node metastasis< 0.0011
Present33 (100.00) 0 (0.001)
Absent73 (42.86) 4 (57.14)
Table 5 Correlation between relative bacterial load of Streptococcus pharyngitidis and pathological characteristics in patients with gastrointestinal tumors
Pathological characteristics
Relative bacterial load of S. anginosus
r value
P value
Mucosal inflammation score0.436< 0.001
Tumor invasion depth0.382< 0.001
Table 6 Multivariate analysis of factors affecting gastrointestinal tumors
Factors
β
SE
χ²
OR
95%CI
P value
Gender-2.0080.5006.7460.1350.050-0.3580.744
Age1.8900.60911.0291.3891.642-2.5980.004
Smoking-2.0000.5096.8410.1390.113-0.1610.722
Alcohol consumption-2.0110.5136.8020.1350.049-0.3660.613
S. anginosus positivity1.4860.73614.5392.3851.846-5.102< 0.001
Helicobacter pylori infection-2.0150.5106.9400.1330.049-0.3620.849
Table 7 Comparison of tumor burden between different model groups, mean ± SD
Group
Tumor nodules (n)
Maximum diameter (mm)
Tumor volume (mm3)
Tumor weight (g)
Normal control group (n = 5)0.11 ± 0.02---
Gastric cancer model group (n = 5)4.62 ± 0.21a6.85 ± 0.66185.46 ± 16.220.86 ± 0.02
Gastric cancer + S. anginosus intervention group (n = 5)6.28 ± 0.36a,b8.41 ± 0.52248.63 ± 20.171.17 ± 0.09
F/t value878.84.1525.4637.518
P value< 0.0010.0030.001< 0.001
Table 8 Comparison of serum interleukin-6 and tumor necrosis factor-α levels between different model groups, mean ± SD
Group
IL-6 (pg/mL)
TNF-α (pg/mL)
Normal control group (n = 5)20.02 ± 3.2216.41 ± 2.33
Gastric cancer model group (n = 5)76.48 ± 5.96a60.58 ± 8.26
Gastric cancer + S. anginosus intervention group (n = 5)102.71 ± 8.52a,b84.23 ± 10.12
F value225.6101.0
P value< 0.001< 0.001
Table 9 Comparison of immune cell infiltration between different model groups, mean ± SD
Group
CD4+ T
CD8+ T
CD68+ macrophages
Normal control group (n = 5)8.42 ± 3.146.58 ± 1.165.87 ± 0.74
Gastric cancer model group (n = 5)24.68 ± 6.22a18.74 ± 2.52a22.18 ± 3.06a
Gastric cancer + S. anginosus intervention group (n = 5)36.55 ± 7.51a,b26.47 ± 3.44a,b29.85 ± 3.71a,b
F value28.5077.2295.02
P value< 0.001< 0.001< 0.001
Table 10 Relationship between relative bacterial load of pharyngitis streptococcus and serum interleukin-6, tumor necrosis factor-α levels, and immune cell infiltration score
IndicatorsRelative bacterial load of S. anginosus
r value
P value
IL-60.458< 0.001
TNF-α0.469< 0.001
CD4+ T cell infiltration score0.587< 0.001
CD8+ T cell infiltration score0.506< 0.001
CD68+ macrophage infiltration score0.545< 0.001


Write to the Help Desk